Cardinal Health completes
$1.944B acquisition of Cordis Cardinal Health (Dublin, OH) completed the acquisition of Cordis (Fremont, CA), Johnson & Johnson’s (New Brunswick, NJ) cardiology and endovascular device business, for $1.944 billion. Cordis products will continue to be sold under the Cordis brand name but with a logo that identifies Cordis as a Cardinal Health company. The business will report to Don Casey, Cardinal Health’s Medical segment chief executive officer. David Wilson remains as Cordis’ worldwide president, and the Cordis team continues to be based in the San Francisco Bay Area. In addition, global headquarters and a Europe, Middle East and Africa hub have been established in Zug, Switzerland. Singapore will serve as the Asia-Pacific hub, and Puerto Rico will serve as the Latin American hub. Approximately 3,000 employees will join Cardinal Health when all integration work and transitions are completed over the next few years. The organization will have operations in countries around the world.
Owens & Minor names W. Marshall Simpson as chief commercial officer
Owens & Minor Inc (Richmond, VA) named W. Marshall Simpson as EVP and chief commercial officer effective October 4, 2015. Simpson most recently served as CEO of Dominions Medical (Richmond, VA), a consulting firm he founded to advise new and existing medical and technology companies. Prior to that, he worked for twenty years at Owens & Minor, eventually serving as SVP of sales, operations, and marketing from 2007 to 2011.